शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
PARKHOSPSNSEPARK MEDI WORLD LIMITED· Healthcare ServicesHighNeutral
Announced Mon, 3 Aug, 2026 · 09:31 IST

Park Medi World Q1 PAT up 35% to Rs 88.6 Cr; buys Mehar Hospital for Rs 107 Cr

Profit growth above 25%Results View source PDFExplain this filing

PARKHOSPS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.4%Reaction day
₹293.05
prior close
₹296.35
announcement price
In-mkt
timing
Nifty Microcap 250market+1.3%-3.7% vs market
Hospital peers, median of 25sector+0.5%-2.9% vs sector

On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 2.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
+0.5
15m
+0.4
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.4+1.3-3.7+0.5-2.9
Next day
-3.4+1.8-5.2+0.2-3.7
2d
-2.7+3.1-5.8-0.1-2.7
3d
-0.7+3.5-4.2+0.4-1.1
4d
-0.6+3.5-4.1+1.7-2.3
5d
-1.4+3.4-4.8+2.9-4.3
1w
-3.5+3.6-7.1-0.4-3.1
15d
-4.1+4.9-9.0-2.6-1.6
1m
-2.6+4.4-7.0-2.7+0.2
2m
-7.9+2.9-10.8-10.7+2.8
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated revenue grew 19% YoY to Rs 475.7 Cr and PAT rose 35% to Rs 88.6 Cr in Q1 FY27. Standalone revenue grew 22% to Rs 33.5 Cr but PAT dropped sharply to Rs 1.1 Cr from Rs 8.6 Cr. Board approved 100% acquisition of Mehar Hospital-Zirakpur (150+ beds) for Rs 107 Cr in cash. Company also seeks shareholder approval to vary IPO proceeds objects via postal ballot. Plans about 1,500 bed additions this year, targeting 5,800 beds by March 2028.

Likely market impact

Strong consolidated earnings growth and major expansion push. Standalone PAT weak. IPO object variation needs shareholder approval.